Please ensure Javascript is enabled for purposes of website accessibility
Skip to main content
Poised to address unmet need in neuromuscular diseases and
positioned for growth

Analyst Coverage

Analyst Coverage

Firm Analyst
Bernstein SG
William Pickering, M.D.
Chardan
Keay Nakae
Evercore ISI
Gavin Clark-Gartner
Guggenheim Securities
Debjit Chattopadhyay, Ph.D.
H.C. Wainwright
Andrew Fein
J.P. Morgan
Tessa Romero
Jefferies
Andrew Tsai
Life Sci Capital
Francois Brisebois
Jones Research
Catherine Novack
Morgan Stanley
Michael Ulz
Oppenheimer
Kostas Biliouris, Ph.D.
Piper Sandler
Edward Tenthoff
Raymond James & Associates
Martin Auster, M.D.
RBC Capital Markets
Luca Issi
Robert W. Baird & Co.
Brian Skorney
Stifel
Paul Matteis

Dyne Therapeutics, Inc. is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Dyne Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Dyne Therapeutics, Inc. or its management. Dyne Therapeutics, Inc. does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.